IPAR INTERPARFUMS INC
Perfumes, Cosmetics & Other Toilet Preparations · Nasdaq · SEC CIK 822663 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY2.6%
TTM net income YoY3.4%
TTM EPS YoY3.3%
Revenue 3-yr CAGR4.9%
Net income 3-yr CAGR2.3%
Margins
Gross margin64.8%
Operating margin17.9%
Net margin11.3%
FCF margin16.2%
EBITDA margin19.5%
Returns
ROE19.5%
ROA10.8%
ROIC (approx.)19.0%
Asset turnover0.96x
Leverage & solvency
Liabilities / assets30.1%
Debt / equity0.22x
Current ratio3.33x
Interest coverage44.33x
Cash quality & payout
Operating cash flow / net income1.46x
Accruals ratio-5.0%
Payout ratio60.2%
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $429.51M | $341.04M | $344.88M | $386.18M | $429.58M | $333.94M | $338.82M | $361.50M |
| Cost of revenue | $141.31M | $117.51M | $120.25M | $148.84M | $156.76M | $112.85M | $122.84M | $128.47M |
| Gross profit | $288.20M | $223.53M | $224.64M | $237.34M | $272.82M | $221.09M | $215.98M | $233.04M |
| SG&A expense | $170.32M | $174.58M | $150.50M | $209.83M | $164.26M | $161.91M | $140.90M | $193.03M |
| Operating income | $117.87M | $48.94M | $74.13M | $27.51M | $108.56M | $59.18M | $75.08M | $36.00M |
| Interest expense | $1.55M | $1.46M | $1.43M | $1.61M | $2.31M | $1.79M | $1.54M | $2.10M |
| Pretax income | $117.45M | $48.25M | $75.21M | $36.23M | $107.56M | $54.12M | $73.41M | $36.68M |
| Income tax | $29.27M | $11.36M | $18.50M | $7.97M | $24.28M | $12.93M | $18.01M | $9.98M |
| Net income | $68.20M | $30.49M | $43.37M | $28.10M | $65.81M | $31.99M | $42.49M | $24.23M |
| EBITDA | $123.93M | $54.77M | $79.93M | $33.97M | $115.10M | $65.54M | $81.00M | $46.16M |
| EPS (basic) | 2.13 | 0.95 | 1.35 | — | 2.05 | 1.00 | 1.32 | — |
| EPS (diluted) | 2.13 | 0.95 | 1.35 | — | 2.05 | 0.99 | 1.32 | — |
| Dividends declared per share | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.75 |
| Weighted avg. shares (diluted) | 32.04M | 32.03M | 32.03M | — | 32.15M | 32.15M | 32.17M | — |
| Balance sheet | ||||||||
| Short-term investments | $108.33M | $41.64M | $157.21M | $137.09M | $77.46M | $53.90M | $75.31M | $109.31M |
| Receivables | $375.41M | $301.83M | $332.73M | $320.62M | $363.62M | $296.04M | $302.27M | $274.70M |
| Inventory | $376.15M | $375.58M | $369.63M | $351.38M | $388.30M | $425.35M | $395.89M | $371.92M |
| Current assets | $1.04B | $950.97M | $997.77M | $1.03B | $990.74M | $986.99M | $911.07M | $926.40M |
| PP&E, net | $174.43M | $176.17M | $179.39M | $184.89M | $186.21M | $185.36M | $158.85M | $153.77M |
| Intangibles | $308.26M | $311.92M | $317.03M | $325.19M | $328.22M | $333.35M | $312.26M | $282.48M |
| Total assets | $1.58B | $1.49B | $1.54B | $1.59B | $1.56B | $1.56B | $1.44B | $1.41B |
| Current liabilities | $313.25M | $287.32M | $305.93M | $344.00M | $302.77M | $333.00M | $306.45M | $332.43M |
| Short-term debt | $43.08M | $46.32M | $50.16M | $54.77M | $56.90M | $56.74M | $43.42M | $41.61M |
| Long-term debt | $147.38M | $96.52M | $107.19M | $121.25M | $139.98M | $153.11M | $107.37M | $115.73M |
| Total debt | $190.47M | $142.84M | $157.35M | $176.03M | $196.88M | $209.86M | $150.79M | $157.34M |
| Total liabilities | $473.79M | $399.41M | $430.23M | $481.22M | $460.15M | $505.00M | $433.01M | $468.62M |
| Shareholders' equity | $878.47M | $870.46M | $881.64M | $880.72M | $870.89M | $839.36M | $788.64M | $744.87M |
| Shares outstanding | 32.03M | 32.03M | 32.03M | 32.07M | 32.06M | 32.12M | 32.12M | 32.11M |
| Cash flow statement | ||||||||
| Operating cash flow | $56.67M | $45.58M | $85,000 | $146.53M | $63.86M | $11.87M | -$7.36M | $137.96M |
| Capital expenditure | $1.51M | $1.03M | $1.36M | $1.55M | $6.24M | $15.19M | $1.44M | $1.85M |
| Free cash flow | $55.16M | $44.56M | -$1.28M | $144.98M | $57.63M | -$3.32M | -$8.80M | $136.11M |
| Investing cash flow | -$70.46M | $114.95M | -$26.60M | -$59.30M | -$26.08M | $10.72M | $13.51M | -$56.40M |
| Financing cash flow | -$25.90M | -$69.78M | -$50.39M | -$40.40M | -$78.24M | $25.83M | -$38.44M | -$28.84M |
| Depreciation & amortization | $6.06M | $5.83M | $5.80M | $6.47M | $6.54M | $6.36M | $5.93M | $10.16M |
| Stock-based compensation | $425,000 | $425,000 | $425,000 | $255,000 | $370,000 | $390,000 | $559,000 | $611,000 |
| Dividends paid | $25.62M | $25.62M | $25.64M | $25.63M | $25.70M | $25.69M | $25.70M | $24.04M |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.